Aehr Test Systems Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $50M-15.2% YoYTTM through 29 May 2026
Net Income -$7.1MTTM through 28 Nov 2025
Free Cash Flow -$5.4MTTM through 29 May 2026
Margins
| Current | |
|---|---|
| Gross Margin | 32.7% |
| EBITDA Margin | -22.7% |
| Operating Margin | -38.8% |
| Net Margin | -14.3% |
Returns
-8.2%ROE
-7.3%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio10.97x
Net Debt-$36.9Mnet cash position
Cash & Equivalents$116.4M
Quality Metrics
Altman Z-Score73.17
Piotroski F-Score1 / 9
FCF Margin-10.8%
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2026: $50M
Diluted EPS-$0.23TTMFY2026: $-0.23
Dividend
No dividend
Capital Allocation
R&D Spend$12.6M
Capex Intensity4.1%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.